BAT-7104

N/A

Report date: 2025/07/03 15:42:40

Base Information

Drug NameBAT-7104

Drug Alias NameBAT-7104

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionProgrammed death-ligand 1 blockersCluster of differentiation 47 inhibitors

TargetsProgrammed death-ligand 1Cluster of differentiation 47

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustraliaMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBio-Thera Solutions Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBio-Thera Solutions Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A